1. Our commitment
BionicMed Ltd is committed to ensuring that bionicmed.eu is accessible to the widest possible audience, regardless of technology, ability, or circumstance.
We believe accessibility is not an add-on — it is a fundamental quality requirement for any digital service. This is particularly important to us given BionicMed's focus on assistive technology and healthcare: the people our work ultimately serves often live with disabilities themselves.
We continuously work to improve the accessibility of this website in accordance with the Web Content Accessibility Guidelines (WCAG) 2.2.
2. Standard we aim for
We aim to meet WCAG 2.2 Level AA — the standard referenced in:
- The UK Public Sector Bodies (Websites and Mobile Applications) Accessibility Regulations 2018 (SI 2018/952).
- The European Accessibility Act (EAA / Directive 2019/882), which is progressively coming into force.
- The Equality Act 2010 (UK), which requires reasonable adjustments for disabled people.
WCAG 2.2 is organised around four principles: content must be Perceivable, Operable, Understandable, and Robust. Level AA encompasses all Level A criteria plus additional Level AA requirements.
3. Built-in accessibility features
This website includes an Accessibility Panel (the ⓘ button fixed to the right side of the screen) that allows you to customise your viewing experience without changing your browser or operating system settings:
Text size adjustment
Increase or decrease the base font size in steps of 2px, from −4px to +8px relative to default. Works independently of your browser's zoom.
Dyslexia-friendly font
Switches body text to OpenDyslexic, a typeface designed to aid readers with dyslexia by using heavier bottoms to indicate reading direction.
Extended spacing
Increases letter spacing, word spacing, and line height throughout the page to aid readability for users with cognitive or visual processing differences.
High contrast
Enforces maximum contrast between text and backgrounds (near-black on white, or near-white on dark), exceeding WCAG 2.2 enhanced contrast ratio of 7:1.
Reduce animations
Disables all non-essential animations and transitions on the page. Equivalent to the OS-level "reduce motion" preference, applied specifically to this site.
Dark / light mode
Toggle between light and dark colour schemes using the sun/moon icon in the navigation bar. Your preference is saved across visits.
All accessibility settings are saved in your browser's localStorage and persist across pages and visits until you clear them.
Additional built-in measures
- Semantic HTML: Correct heading hierarchy (h1 → h2 → h3), landmark regions (
nav,main,footer,aside), and list structures throughout. - Skip to content link: A visually hidden "Skip to main content" link appears on focus, allowing keyboard users to bypass the navigation.
- ARIA labels: All interactive controls without visible text labels include
aria-labeloraria-labelledbyattributes. - Focus visibility: All interactive elements have clearly visible keyboard focus indicators meeting WCAG 2.2 Success Criterion 2.4.11 (Focus Appearance).
- Colour contrast: Normal text meets a minimum contrast ratio of 4.5:1 against its background; large text meets 3:1.
- Responsive design: The layout adapts to viewport widths from 320px upward without horizontal scrolling.
- No content that causes seizures: No flashing content above 3 Hz that could trigger photosensitive seizures.
- SVG accessibility: All decorative SVGs are marked
aria-hidden="true"; informative SVGs include appropriate ARIA attributes. - Form error handling: Form validation errors are announced via
aria-liveregions and associated with their fields usingaria-describedby. - Language declaration: The primary language of each page is declared via
lang="en"on the<html>element.
4. Compliance status
This website is partially compliant with WCAG 2.2 Level AA. We are working toward full compliance. The known non-conformances and limitations are detailed in section 5 below.
| WCAG principle | Level A | Level AA |
|---|---|---|
| 1. Perceivable | ✔ Meets | ✔ Meets |
| 2. Operable | ✔ Meets | ✔ Meets |
| 3. Understandable | ✔ Meets | ✔ Meets |
| 4. Robust | ✔ Meets | ◑ Partially meets |
This self-assessment was prepared in January 2025 during the initial site build. A formal third-party audit is planned for Q2 2025.
5. Known issues and limitations
We are aware of the following issues and are working to resolve them:
| Issue | WCAG criterion affected | Impact | Target resolution |
|---|---|---|---|
| Third-party fonts (Google Fonts) loaded from external CDN — may fail in high-privacy browser configurations, causing fallback typography | 1.4.4 Resize text (AA) | Low — fallback fonts remain readable | Q2 2025 — self-hosted fonts |
| Dashboard visualisation (on BionicMove page) uses decorative SVG with no data table alternative | 1.1.1 Non-text content (A) | Medium — decorative mock-up, no real data conveyed | Q2 2025 — add data table or aria-hidden |
| Contact form does not prevent submission while validation is pending (brief window) | 3.3.1 Error identification (A) | Low — errors are announced and inline | Q1 2025 — fix in next release |
| No CAPTCHA alternative for contact form | — | None currently (no CAPTCHA in use) | If CAPTCHA added, audio alternative will be included |
If you encounter an accessibility barrier not listed above, please report it using the contact details in section 8.
6. Technical information
BionicMed Ltd relies on the following technologies for conformance with WCAG 2.2:
- HTML5 — semantic markup and ARIA roles
- CSS3 — responsive layout, focus indicators, reduced motion support via
@media (prefers-reduced-motion) - JavaScript (ES6+) — interactive components with full keyboard and ARIA support
The site is designed to work with the following assistive technologies and browser combinations:
- NVDA + Chrome (Windows)
- JAWS + Edge (Windows)
- VoiceOver + Safari (macOS / iOS)
- TalkBack + Chrome (Android)
- Keyboard-only navigation (all major browsers)
Technologies we do not rely on for accessibility: Flash, Java applets, PDFs (none in use), or browser plug-ins.
7. Testing approach
We use a combination of automated and manual testing:
- Automated tools: axe DevTools, WAVE Evaluation Tool, and Lighthouse accessibility audits used during development.
- Manual keyboard testing: Tab navigation, focus management, modal trapping, and skip links tested manually in Chrome and Firefox.
- Screen reader testing: Pages tested with NVDA + Chrome and VoiceOver + Safari.
- Colour contrast: All text/background combinations verified using the WebAIM Contrast Checker.
- Zoom testing: Pages tested at 200% and 400% browser zoom.
A third-party accessibility audit against WCAG 2.2 Level AA is planned for Q2 2025. Results will be published and this statement updated accordingly.
8. Feedback and contact
We welcome feedback on the accessibility of this website. If you:
- encounter an accessibility barrier not covered in this statement,
- find that a page or feature does not meet the accessibility standard we have described,
- need content in an alternative format (e.g. large print, plain text, audio description), or
- have a suggestion for improving accessibility,
please contact us:
BionicMed Ltd — AccessibilityUse our contact form →
Please select Accessibility as the subject.
Please include a description of the accessibility barrier and the page URL where you encountered it. We aim to respond within 5 business days and to provide an accessible alternative or resolve the issue within 20 business days.
9. Enforcement
If you are not satisfied with our response to your accessibility feedback, you may contact the relevant enforcement body:
-
United Kingdom — Equality and Human Rights Commission (EHRC):
equalityhumanrights.com/en/contact-us -
Northern Ireland — Equality Commission for Northern Ireland (ECNI):
equalityni.org - European Union — relevant national accessibility authority in your member state.
We would appreciate the opportunity to address your concerns before you contact an enforcement body.
10. Statement review
This statement was prepared in January 2025 based on a self-assessment of bionicmed.eu against WCAG 2.2 Level AA criteria. It will be reviewed and updated:
- Following any material changes to the website.
- After formal accessibility audits.
- At least annually.
The next scheduled review is January 2026.